Hubei Biocause Pharmaceutical Co., Ltd.

30
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: CNE000000F48
CNY
1.58
-1.46 (-48.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
No of Months
12
12
12
12
12
12
Operating Income
49,321.00
49,475.00
49,042.00
41,261.00
49,340.00
30,110.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
49,321.00
49,475.00
49,042.00
41,261.00
49,340.00
30,110.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
649.00
670.00
716.00
604.00
754.00
787.00
Operating Expenses
808.00
691.00
423.00
170.00
101.00
118.00
General and Administration Expenses
4,871.00
4,706.00
4,829.00
685.00
5,598.00
2,739.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
47,836.00
48,884.00
47,768.00
39,221.00
45,962.00
26,631.00
Operating Profit (PBDIT) excl Other Income
1,485.00
591.00
1,273.00
2,040.00
3,377.00
3,479.00
Other Income
9.00
116.00
38.00
344.00
850.00
184.00
Operating Profit (PBDIT)
174.00
282.00
189.00
424.00
941.00
288.00
Interest
808.00
691.00
423.00
170.00
101.00
118.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
165.00
166.00
151.00
79.00
91.00
103.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-1,972.00
-131.00
-65.00
2,682.00
3,484.00
2,487.00
Provision for Tax
-586.00
-285.00
-537.00
331.00
714.00
259.00
Profit After Tax
-1,281.00
510.00
880.00
1,117.00
2,918.00
2,377.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.13
0.06
0.10
0.12
0.00
0.00
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is -0.31% vs 0.88% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 151.24% vs -53.59% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 16.99% vs 63.05% in Dec 2022

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2023 is -350.97% vs -41.99% in Dec 2022

Compare Profit and Loss Results of Hubei Biocause Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
49,321.00
0
49,321.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
49,321.00
0
49,321.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
649.00
0
649.00
0%
Operating Expenses
808.00
0
808.00
0%
General and Administration Expenses
4,871.00
0
4,871.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
47,836.00
0
47,836.00
0%
Operating Profit (PBDIT) excl Other Income
1,485.00
0.00
1,485.00
0%
Other Income
9.00
0
9.00
0%
Operating Profit (PBDIT)
174.00
0
174.00
0%
Interest
808.00
0
808.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
165.00
0
165.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
-1,972.00
0
-1,972.00
0%
Provision for Tax
-586.00
0
-586.00
0%
Profit After Tax
-1,281.00
0
-1,281.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.1319
0
-0.13
0%
Profit And Loss - Net Sales
Net Sales 49,321.77 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -0.31% vs 0.88% in Dec 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,485.10 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 151.24% vs -53.59% in Dec 2022

Profit And Loss - Interest
Interest 808.44 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 16.99% vs 63.05% in Dec 2022

Profit And Loss - Profit After Tax
Profit After Tax -1,281.50 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -350.97% vs -41.99% in Dec 2022